Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multilayered deal with PathAI—acquiring some assets and licensing out others. The testing ...

First-of-its-kind digital pathology network powered by PathAI’s AISight® platform expands access to latest AI products, unlocks real-world data value, and fuels collaborative research with biopharma ...

VC funding into AI tools for healthcare was projected to hit $11 billion last year — a headline figure that speaks to the widespread conviction that artificial intelligence will prove transformative ...